| Market Cap | ₹7,713Cr |
| ROE | 13.69% |
| P/E Ratio(TTM) | 28.95 |
| EPS(TTM) | 29.39 |
| P/B Ratio | 3.88 |
| Dividend Yield | 0.59% |
| Industry P/E | 34.63 |
| Book Value | 219.52 |
| Debt to Equity | 0.21 |
| Face Value | 5 |
| Parent Organisation | Aarti Pharmalabs |
| NSE Symbol | AARTIPHARM |
| FUND NAME | AUM(%) |
|---|---|
| HDFC Multi Cap Fund Direct Growth | 0.19% |
| HDFC Large and Mid Cap Fund Direct Growth | 0.02% |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 87.58 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.40 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.46 | ||
| Wockhardt | NA (0.00%) | -139.73 |